AS1810722
AS1810722 is an orally active and potent STAT6 inhibitor (IC50 :1.9 nM) . AS1810722 shows a good profile of CYP3A4 inhibition. AS1810722, a derivative of fused bicyclic pyrimidine, has the potential for allergic diseases such as asthma and atopic diseases research.
Product Specifications
CAS Number
909561-15-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
477.52
Molecular Formula
C25H25F2N7O
Notes
Research use only, not for human use.
Receptor
CYP3A4|STAT6
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC211986L2V 200 µL
ETAA1 (NM_019002) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 
GA103453 1 Kit
Human PDGF Receptor alpha (PDGFRA) activation kit by CRISPRa
Sign In for Pricing
View Details 
orb2961398-02 100 µg
Recombinant Human CD156b/ADAM17 Protein, C-His
Sign In for Pricing
View Details